X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs UNICHEM LAB - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER UNICHEM LAB PFIZER/
UNICHEM LAB
 
P/E (TTM) x 34.6 284.8 12.2% View Chart
P/BV x 5.5 0.7 837.2% View Chart
Dividend Yield % 0.6 2.6 24.1%  

Financials

 PFIZER   UNICHEM LAB
EQUITY SHARE DATA
    PFIZER
Mar-18
UNICHEM LAB
Mar-18
PFIZER/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs2,365382 619.1%   
Low Rs1,625234 694.1%   
Sales per share (Unadj.) Rs430.3116.3 370.0%  
Earnings per share (Unadj.) Rs78.7-18.9 -416.0%  
Cash flow per share (Unadj.) Rs93.2-11.7 -793.7%  
Dividends per share (Unadj.) Rs20.005.00 400.0%  
Dividend yield (eoy) %1.01.6 61.8%  
Book value per share (Unadj.) Rs586.5381.0 153.9%  
Shares outstanding (eoy) m45.7570.34 65.0%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x4.62.6 175.0%   
Avg P/E ratio x25.3-16.3 -155.7%  
P/CF ratio (eoy) x21.4-26.2 -81.6%  
Price / Book Value ratio x3.40.8 420.7%  
Dividend payout %25.4-26.4 -96.2%   
Avg Mkt Cap Rs m91,27121,668 421.2%   
No. of employees `0002.62.3 115.4%   
Total wages/salary Rs m3,1432,006 156.6%   
Avg. sales/employee Rs Th7,484.83,587.8 208.6%   
Avg. wages/employee Rs Th1,195.0880.0 135.8%   
Avg. net profit/employee Rs Th1,369.1-583.7 -234.5%   
INCOME DATA
Net Sales Rs m19,6858,180 240.6%  
Other income Rs m1,143610 187.3%   
Total revenues Rs m20,8288,790 236.9%   
Gross profit Rs m5,003-1,320 -379.0%  
Depreciation Rs m663505 131.2%   
Interest Rs m480 5.2%   
Profit before tax Rs m5,479-1,295 -423.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,87833 5,620.6%   
Profit after tax Rs m3,601-1,331 -270.5%  
Gross profit margin %25.4-16.1 -157.5%  
Effective tax rate %34.3-2.6 -1,328.7%   
Net profit margin %18.3-16.3 -112.4%  
BALANCE SHEET DATA
Current assets Rs m24,16723,318 103.6%   
Current liabilities Rs m9,5444,635 205.9%   
Net working cap to sales %74.3228.4 32.5%  
Current ratio x2.55.0 50.3%  
Inventory Days Days55122 45.2%  
Debtors Days Days29121 23.6%  
Net fixed assets Rs m9,5148,163 116.5%   
Share capital Rs m458141 325.2%   
"Free" reserves Rs m26,37526,660 98.9%   
Net worth Rs m26,83226,801 100.1%   
Long term debt Rs m253 757.6%   
Total assets Rs m36,90031,890 115.7%  
Interest coverage x1,305.5-15.2 -8,605.5%   
Debt to equity ratio x00 756.7%  
Sales to assets ratio x0.50.3 208.0%   
Return on assets %9.8-3.9 -249.1%  
Return on equity %13.4-5.0 -270.2%  
Return on capital %20.4-4.5 -449.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m224,356 0.5%   
Fx outflow Rs m1,4890-   
Net fx Rs m-1,4664,356 -33.7%   
CASH FLOW
From Operations Rs m3,318-1,123 -295.4%  
From Investments Rs m-2,38316,487 -14.5%  
From Financial Activity Rs m-1,104-8,811 12.5%  
Net Cashflow Rs m-1696,552 -2.6%  

Share Holding

Indian Promoters % 0.0 50.1 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 15.1 49.7%  
FIIs % 4.9 3.0 163.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 31.7 74.8%  
Shareholders   85,207 20,176 422.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   DIVIS LABORATORIES  WOCKHARDT  AUROBINDO PHARMA  FRESENIUS KABI ONCO.  GLENMARK PHARMA  

Compare PFIZER With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex at New Highs, Jet Airways Suspends Operations - Your Inside Scoop of the Markets(Podcast)

Jet Airways, once India's largest private airline halted its operations indefinitely yesterday. The carrier flew its last scheduled flight from Amritsar to Mumbai yesterday.

Related Views on News

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

PFIZER Announces Quarterly Results (2QFY19); Net Profit Down 13.8% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, PFIZER has posted a net profit of Rs 958 m (down 13.8% YoY). Sales on the other hand came in at Rs 5 bn (down 9.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Apr 18, 2019 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS